Michael Udelhoven

776 total citations
14 papers, 645 citations indexed

About

Michael Udelhoven is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Udelhoven has authored 14 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Udelhoven's work include Metabolism, Diabetes, and Cancer (4 papers), Alzheimer's disease research and treatments (3 papers) and Adipose Tissue and Metabolism (3 papers). Michael Udelhoven is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Alzheimer's disease research and treatments (3 papers) and Adipose Tissue and Metabolism (3 papers). Michael Udelhoven collaborates with scholars based in Germany, Japan and India. Michael Udelhoven's co-authors include Wilhelm Krone, Markus Schubert, S Freude, Uschi Leeser, Jens C. Brüning, Moritz M. Hettich, Oliver Stöhr, J Schnitker, Christoph Köhler and Hannsjörg Schröder and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and The FASEB Journal.

In The Last Decade

Michael Udelhoven

13 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Udelhoven Germany 11 300 265 114 85 77 14 645
Moritz M. Hettich Germany 11 384 1.3× 325 1.2× 101 0.9× 120 1.4× 76 1.0× 12 777
Uschi Leeser Germany 10 333 1.1× 205 0.8× 98 0.9× 73 0.9× 53 0.7× 11 593
Ashay D. Bhatwadekar United States 23 547 1.8× 180 0.7× 140 1.2× 95 1.1× 97 1.3× 56 1.3k
Désirée Rutschow Germany 7 403 1.3× 226 0.9× 79 0.7× 97 1.1× 59 0.8× 8 612
Katharina Schilbach Germany 17 224 0.7× 186 0.7× 382 3.4× 59 0.7× 143 1.9× 57 868
Taro Katsuno Japan 8 194 0.6× 322 1.2× 47 0.4× 46 0.5× 51 0.7× 9 722
Donghe Han China 15 274 0.9× 87 0.3× 46 0.4× 86 1.0× 114 1.5× 18 676
Shanthie Thamotharan United States 18 404 1.3× 288 1.1× 95 0.8× 76 0.9× 101 1.3× 34 1.0k
Gavin Pharaoh United States 17 495 1.6× 350 1.3× 64 0.6× 58 0.7× 28 0.4× 26 766
Sang Su Oh United States 14 371 1.2× 342 1.3× 84 0.7× 201 2.4× 68 0.9× 17 949

Countries citing papers authored by Michael Udelhoven

Since Specialization
Citations

This map shows the geographic impact of Michael Udelhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Udelhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Udelhoven more than expected).

Fields of papers citing papers by Michael Udelhoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Udelhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Udelhoven. The network helps show where Michael Udelhoven may publish in the future.

Co-authorship network of co-authors of Michael Udelhoven

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Udelhoven. A scholar is included among the top collaborators of Michael Udelhoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Udelhoven. Michael Udelhoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zemva, Johanna, Michael Udelhoven, Lorna Moll, et al.. (2012). Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging. AGE. 35(5). 1881–1897. 9 indexed citations
2.
Stöhr, Oliver, Katharina Schilbach, Lorna Moll, et al.. (2011). Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease. AGE. 35(1). 83–101. 59 indexed citations
3.
Stöhr, Oliver, Lorna Moll, Uschi Leeser, et al.. (2011). Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(5). 573–580. 14 indexed citations
4.
Udelhoven, Michael, Uschi Leeser, S Freude, et al.. (2009). Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells. Journal of Molecular Endocrinology. 44(2). 99–113. 17 indexed citations
5.
Udelhoven, Michael, et al.. (2009). Neuronal insulin receptor substrate 2 (IRS2) expression is regulated by ZBP89 and SP1 binding to the IRS2 promoter. Journal of Endocrinology. 204(2). 199–208. 9 indexed citations
6.
Schulte, Dominik M., F. Oberhäuser, Michael Udelhoven, et al.. (2009). Role of Wnt-5a in the Determination of Human Mesenchymal Stem Cells into Preadipocytes. Journal of Biological Chemistry. 285(9). 6170–6178. 89 indexed citations
7.
Freude, S, Moritz M. Hettich, C Schumann, et al.. (2009). Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease. The FASEB Journal. 23(10). 3315–3324. 186 indexed citations
8.
Laudes, Matthias, F. Oberhäuser, Markus Schubert, et al.. (2008). Human Fetal Adiponectin and Retinol-binding Protein (RBP)-4 Levels in Relation to Birth Weight and Maternal Obesity. Experimental and Clinical Endocrinology & Diabetes. 117(3). 146–149. 18 indexed citations
9.
Freude, S, Uschi Leeser, Moritz M. Hettich, et al.. (2008). IRS‐2 branch of IGF‐1 receptor signaling is essential for appropriate timing of myelination. Journal of Neurochemistry. 107(4). 907–917. 51 indexed citations
10.
Laudes, Matthias, et al.. (2008). Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4. Journal of Molecular Medicine. 86(5). 597–608. 33 indexed citations
11.
12.
Freude, S, Leona Plum, J Schnitker, et al.. (2005). Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo. Diabetes. 54(12). 3343–3348. 119 indexed citations
13.
Freidel, Kerstin, Michael Udelhoven, Thomas Hohlfeld, et al.. (2004). Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thrombosis and Haemostasis. 92(11). 925–928. 26 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moritz M. Hettich Breakdown of academic impact, for papers by Uschi Leeser Breakdown of academic impact, for papers by Ashay D. Bhatwadekar Breakdown of academic impact, for papers by Désirée Rutschow Breakdown of academic impact, for papers by Katharina Schilbach Breakdown of academic impact, for papers by Taro Katsuno Breakdown of academic impact, for papers by Donghe Han Breakdown of academic impact, for papers by Shanthie Thamotharan Breakdown of academic impact, for papers by Gavin Pharaoh Breakdown of academic impact, for papers by Sang Su Oh
Rankless by CCL
2026